- Home
- EXEL vs SIRI Comparison
EXEL vs SIRI Comparison
Compare EXEL & SIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- SIRI
- Stock Information
- Founded
- EXEL 1994
- SIRI 2013
- Country
- EXEL United States
- SIRI United States
- Employees
- EXEL N/A
- SIRI N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- SIRI Broadcasting
- Sector
- EXEL Health Care
- SIRI Consumer Discretionary
- Exchange
- EXEL Nasdaq
- SIRI Nasdaq
- Market Cap
- EXEL 10.4B
- SIRI 8.0B
- IPO Year
- EXEL 2000
- SIRI 1994
- Fundamental
- Price
- EXEL $40.44
- SIRI $23.12
- Analyst Decision
- EXEL Buy
- SIRI Hold
- Analyst Count
- EXEL 22
- SIRI 13
- Target Price
- EXEL $44.00
- SIRI $26.54
- AVG Volume (30 Days)
- EXEL 2.3M
- SIRI 3.1M
- Earning Date
- EXEL 10-28-2025
- SIRI 10-30-2025
- Dividend Yield
- EXEL N/A
- SIRI 4.65%
- EPS Growth
- EXEL 81.76
- SIRI N/A
- EPS
- EXEL 2.08
- SIRI N/A
- Revenue
- EXEL $2,230,005,000.00
- SIRI $8,565,000,000.00
- Revenue This Year
- EXEL $9.19
- SIRI N/A
- Revenue Next Year
- EXEL $12.54
- SIRI N/A
- P/E Ratio
- EXEL $19.56
- SIRI N/A
- Revenue Growth
- EXEL 10.73
- SIRI N/A
- 52 Week Low
- EXEL $25.17
- SIRI $18.69
- 52 Week High
- EXEL $49.62
- SIRI $29.18
- Technical
- Relative Strength Index (RSI)
- EXEL 62.26
- SIRI 48.18
- Support Level
- EXEL $38.37
- SIRI $23.22
- Resistance Level
- EXEL $39.27
- SIRI $24.85
- Average True Range (ATR)
- EXEL 1.03
- SIRI 0.62
- MACD
- EXEL 0.38
- SIRI -0.08
- Stochastic Oscillator
- EXEL 92.53
- SIRI 16.43
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About SIRI Sirius XM Holdings Inc.
Sirius XM operates almost exclusively in the US through its SiriusXM and Pandora audio services. SiriusXM is primarily a satellite radio service that offers nationwide coverage and mostly ad-free listening, with proprietary channels and exclusive content. It makes agreements with automakers to install its radios in vehicles and give trial services to vehicle buyers, which have traditionally fed its subscriber base. The company provides the service through a handful of geostationary satellites that it owns and operates; it now offers a streaming SiriusXM option as well. Pandora, which makes up a much smaller portion of revenue and profit, offers a subscription and ad-supported streaming music service that competes with industry giants like Spotify, Apple Music, and YouTube Music.